Copyright 2001 by the Johns Hopkins University Bloomberg School of Public Health
All rights reserved
Received for publication January 19, 2001, and accepted for publication April 30, 2001.
Abbreviation: CI, confidence interval.
From the Section of Preventive Medicine and Epidemiology,
Evans Department of Medicine, Boston University School of
Medicine, Boston, MA.
Correspondence to Dr. R. Curtis Ellison, Boston University School
of Medicine, 715 Albany Street, Room B-612, Boston, MA 02118 (email: ellison@bu.edu).
740
There are lingering questions regarding the relation between alcohol consumption and breast cancer risk in
women. The authors performed a meta-analysis of epidemiologic studies carried out through 1999 to examine
the dose-response relation and to assess whether effect estimates differed according to various study
characteristics. Overall, there was a monotonic increase in the relative risk of breast cancer with alcohol
consumption, but the magnitude of the effect was small; in comparison with nondrinkers, women averaging 12
g/day of alcohol consumption (approximately one typical drink) had a relative risk of 1.10 (95% confidence
interval (CI): 1.06, 1.14). Estimates of relative risk were 7% greater in hospital-based case-control studies than
in cohort studies or community-based case-control studies, 3% greater in studies published before 1990 than in
studies published later, and 5% greater in studies conducted outside of the United States than in US studies.
The findings of five US cohort studies published since 1990 yielded a relative risk of 1.06 (95% CI: 1.00, 1.11)
for consumers of 12 g/day, as compared with nondrinkers. Cohort studies with less than 10 years of follow-up
gave estimates 11% higher than cohort studies with longer follow-up periods. No meaningful difference was
seen by menopausal status or type of beverage consumed. Am J Epidemiol 2001;154:7407.
1) reported only prevalent cases, 2) included only nonquantifiable alcohol intake data, 3) were based on data from
another publication that was included in the meta-analysis,
4) were from reports published only as letters to the editor
or abstracts, or 5) had implausible outcomes (a criterion
used for only one study (30) that was similarly excluded by
Longnecker (18) as having implausible outcomes).
Of a total of 74 publications considered, we excluded 30.
The present meta-analysis of breast cancer incidence was
based on 42 reports providing data on 41,477 incident cases
of breast cancer. These reports consisted of all of the studies
listed in table 1 except for two studies on breast cancer mortality (49, 50), which provided data on 3,283 cases for a separate analysis. Table 2 shows characteristics of reports that
we considered but excluded and indicates the reasons for
Study
design
Case-control, community controls
Case-control, community controls
Case-control, community controls
Case-control, community controls
Case-control, hospital controls
Case-control, hospital controls
Case-control, community controls
Cohort study
Cohort study
Cohort study
Cohort study
Cohort study
Case-control, hospital controls
Case-control, community controls
Cohort study
Cohort study
Cohort study
Case-control, community controls
Cohort study
Case-control, hospital controls
Case-control, hospital controls
Case-control, hospital controls
Case-control, community controls
Case-control, community controls
Case-control, community controls
Case-control, hospital controls
Case-control, hospital controls
Case-control, community controls
Case-control, community controls
Case-control, hospital controls
Case-control, community controls
Case-control, hospital controls
Cohort study
Cohort study
Case-control, community controls
Case-control, community controls
Case-control, community controls
Cohort study
Case-control, community controls
Case-control, community controls
Cohort study
Cohort study
Case-control, community controls
Cohort study
Pooled analyses
Country
Sweden/Norway
United States
United States
Denmark
Italy
Italy
United States
Canada
United States
United States
United States
United States
United States
United States
United States
United States
Sweden
International
Denmark
Greece
Italy
Switzerland
United States
United States
Spain
United Kingdom
Italy
United States
Sweden
France
Canada
Multiple European countries
United States
United States
United Kingdom
New Zealand
United States
Netherlands
Netherlands
Spain
United States
United States
United States
United States
International
No. of
cases
422
1,013
3,217
544
2,569
210
740
419
350
643
2,933
367
604
1,524
838
303
672
1,573
51
798
2,402
230
1,431
6,662
762
1,116
2,566
1,608
393
349
133
315
121
87
753
840
1,645
405
200
330
1,023
806
506
287
* Some results from these papers were derived from the pooled analysis by Smith-Warner et al. (67).
Data were reported separately for premenopausal and postmenopausal status; entered as two studies.
Pooled data from studies from Argentina (97), Greece (98), Italy (99), Canada (100), Australia (87), and Italy (91).
Entered as three independent studies, because data were reported for three control groups.
Previously unpublished results from the Nurses Health Study that were included in the paper by Smith-Warner et al. (67).
# Entered as two independent studies, because data were reported for two control groups.
TABLE 1. Studies included in a meta-analysis of alcohol consumption and breast cancer incidence or
mortality
742
Ellison et al.
TABLE 2. Studies excluded from a meta-analysis of alcohol consumption and breast cancer incidence
or mortality and reasons for exclusion
Study and year
(ref. no.)
Case-control,
Case-control,
Case-control,
Case-control,
Cohort study
Cohort study
Case-control,
Case-control,
Case-control,
Cohort study
Case-control,
Case-control,
Case-control,
Case-control,
Case-control,
Case-control,
Case-control,
Case-control,
Case-control,
Case-control,
Case-control,
Cohort study
Case-control,
Case-control,
Cohort study
Case-control,
Case-control,
Case-control,
Case-control,
Case-control,
Reason study
was excluded
hospital controls
community controls
hospital controls
hospital controls
community controls
hospital controls
hospital controls
hospital controls
hospital controls
hospital controls
community controls
community controls
community controls
community controls
community controls
community controls
community controls
hospital controls
hospital controls
community controls
hospital controls
community controls
community controls
community controls
hospital controls
Prevalent cases
Data included in separate report
Letter to editor
Insufficient data
Insufficient data
Data included in separate report
Prevalent cases
Insufficient data
Insufficient data
Abstract
Data included in separate report
Insufficient data
Insufficient data
Abstract
Insufficient data
Prevalent cases
Insufficient data
Beverage-specific data only
Abstract
Data included in separate report
Insufficient data
Data included in separate report
Insufficient data
Data included in separate report
Insufficient data
Insufficient data
Data included in separate report
Data included in separate report
Data included in separate report
Implausible outcomes
Study
design
rather than 12 grams of alcohol per day, since any differences would presumably be due to substances other than
alcohol in the different beverages. For breast cancer mortality, results suggested a J-shaped relation between alcohol
consumption and breast cancer deaths, so we did not evaluate the association as a linear relation.
RESULTS
FIGURE 1. Relative risk of breast cancer by alcohol consumption. Based on all studies of incidence listed in table 1, with no adjustments. The
dose-response curve line represents estimates from a smoothed spline regression, with the lower line representing no effect. The y-axis presents relative risks on a log scale.
The dose-response relation between total alcohol consumption and risk of breast cancer, assessed using a spline
regression model, is shown in figure 1. There appeared to be
a monotonic increase in breast cancer relative risk with
increasing alcohol consumption. In comparison with nondrinkers, subjects consuming an average of 6 g of alcohol
per day (approximately one half of a typical drink) had a
4.9 percent increased risk (95 percent confidence interval
(CI): 1.03, 1.07), and those consuming 12 g/day (approximately one drink) and 24 g/day (approximately two drinks)
had 10 percent (95 percent CI: 1.06, 1.14) and 21 percent
(95 percent CI: 1.13, 1.30) increased risks, respectively.
Table 3 presents associations between alcohol consumption and breast cancer risk according to different study
characteristics. Estimates of alcohol effect obtained from
hospital-based case-control studies were slightly higher, on
average, than those from cohort studies (overall relative
risk ratio 1.07, 95 percent CI: 1.00, 1.14). The alcoholbreast cancer relation assessed from community-based
case-control studies was similar to that from cohort studies.
Our analysis also indicated that, overall, studies published
before 1990 showed slightly larger relative risks than studies published later (overall relative risk ratio 1.03, 95
744
Ellison et al.
TABLE 3. Relation of alcohol consumption to breast cancer in a meta-analysis of studies conducted through 1999, according to
study characteristics
Ratio of
relative
risks
95%
confidence
interval
1.10
1.17
1.0
1.07
1.00, 1.14
1.09
1.00
0.95, 1.04
1.08
1.12
1.0
1.03
0.99, 1.08
1.07
1.0
1.13
1.05
1.04
1.0
1.15
1.11
1.06, 1.16
1.17
1.19
1.0
1.02
0.95, 1.09
Reference numbers
of studies included
Type of study*
Cohort study
Hospital-based case-control study
Community-based case-control study
Year of publication
Published during or after 1990
0.99, 1.12
* Data were adjusted for year of publication (<1990 vs. 1990) and location of study (United States vs. other countries).
Reference category.
Data were adjusted for type of study and location of study.
Data were adjusted for type of study and year of publication.
Data were adjusted for year of publication and location of study.
# Data were adjusted for type of study, year of publication, and location of study.
Reference numbers
of
studies included
2, 6, 8, 14, 2023, 4648,
57, 60
2, 6, 8, 14, 2023, 4648,
57, 60
2, 6, 8, 14, 2023, 4648,
57, 60
Relative
risk
for one
drink
per day
Ratio of
relative
risks
1.14
1.0
1.10
0.96
0.91, 1.02
1.14
1.01
0.93, 1.09
95%
confidence
interval
* Data were adjusted for type of study, year of publication, and location of
study. Relative risk estimates presented are for women who consumed one
drink per day (the equivalent of 12 g of ethanol per day) or seven drinks per
week in comparison with nondrinkers of that type of beverage, adjusting for
intake of the other beverages. For consumption of three drinks per week, the
ratio of relative risks for beer versus wine and spirits versus wine would be
0.98 (95% confidence interval: 0.96, 1.01) and 1.00 (95% confidence interval:
0.97, 1.04), respectively.
Reference category.
day (equivalent to 12 g of alcohol) in comparison with subjects consuming none of that beverage; for the ratio of relative risks, we used wine consumers as the referent group.
Because of limited data on higher consumption levels, the
estimates of effect could only be compared for 14 or fewer
drinks per week of each beverage.
As table 4 shows, there were few differences between
intake and breast cancer risk for the different beverages. In
comparison with wine, the relative risk for beer was 0.96
(95 percent CI: 0.91, 1.02); the relative risk associated with
spirits, in comparison with wine, was 1.01 (95 percent CI:
0.93, 1.09). Thus, these analyses did not support the hypothesis that nonalcoholic components of wine modify the
alcohol-breast cancer relation.
Data on breast cancer mortality related to alcohol consumption were available from two cohort studies (49, 50)
with a total of 3,283 deaths from breast cancer. A separate
meta-analysis using a spline regression model suggested a Jshaped relation between alcohol consumption and breast
cancer mortality. The estimated relative risk of breast cancer
mortality was slightly below 1.0 for up to 6 g/day, and it
increased above 1.0 thereafter. Relative risks at 6, 12, and 24
g/day were 0.98, 1.15, and 1.16, respectively.
Am J Epidemiol Vol. 154, No. 8, 2001
Relative risk
for consumption
of 12 g of
alcohol per day
(vs. nondrinking)
Study
characteristic
ACKNOWLEDGMENTS
REFERENCES
1. Sneyd MJ, Paul C, Spears GF, et al. Alcohol consumption
and risk of breast cancer. Int J Cancer 1991;48:81215.
2. Howe G, Rohan T, Decarli A, et al. The association between
alcohol and breast cancer risk: evidence from the combined
analysis of six dietary case-control studies. Int J Cancer
1991;47:70710.
3. Gapstur SM, Potter JD, Sellers TA, et al. Increased risk of
breast cancer with alcohol consumption in postmenopausal
women. Am J Epidemiol 1992;136:122131.
4. Graham S, Zielezny M, Marshall J, et al. Diet in the epidemiology of postmenopausal breast cancer in the New York
State Cohort. Am J Epidemiol 1992;136:132737.
5. Harvey EB, Schairer C, Brinton LA, et al. Alcohol consumption and breast cancer. J Natl Cancer Inst 1987;78:65761.
6. Willett WC, Stampfer MJ, Colditz GA, et al. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med
1987;316:117480.
7. Schatzkin A, Jones DY, Hoover RN, et al. Alcohol consumption and breast cancer in the epidemiologic follow-up study
of the first National Health and Nutrition Examination
Survey. N Engl J Med 1987;316:116973.
8. Ferraroni M, Decarli A, Willett WC, et al. Alcohol and breast
cancer risk: a case-control study from northern Italy. Int J
Epidemiol 1991;20:85964.
9. La Vecchia C, Negri E, Parazzini F, et al. Alcohol and breast
cancer: update from an Italian case-control study. Eur J
Cancer Clin Oncol 1989;25:171117.
746
Ellison et al.
33. Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology 1993;4:21828.
34. Hennekens CH, Rosner B, Cole DS. Daily alcohol consumption and fatal coronary heart disease. Am J Epidemiol 1978;
107:196200.
35. Stampfer MJ, Colditz GA, Willett WC, et al. A prospective
study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319:
26773.
36. Kannel WB, Ellison RC. Alcohol and coronary heart disease:
the evidence for a protective effect. Clin Chim Acta 1996;
246:5976.
37. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective
study of alcohol consumption and risk of coronary disease in
men. Lancet 1991;338:4648.
38. Stampfer MJ, Colditz GA, Willett WC, et al. A prospective
study of moderate alcohol drinking and risk of diabetes in
women. Am J Epidemiol 1988;128:54958.
39. Rimm EB, Chan J, Stampfer MJ, et al. Prospective study of
cigarette smoking, alcohol use, and the risk of diabetes in
men. BMJ 1995;310:5559.
40. Felson DT, Zhang Y, Hannan MT, et al. Alcohol intake and
bone mineral density in elderly men and women: The
Framingham Study. Am J Epidemiol 1995;142:48592.
41. La Vecchia C, Decarli A, Ferraroni M, et al. Alcohol drinking and prevalence of self-reported gallstone disease in the
1983 Italian National Health Survey. Epidemiology 1994;5:
5336.
42. Rothman KJ, Poole C. A strengthening programme for weak
associations. Int J Epidemiol 1988;17:9559.
43. Damianaki A, Bakogeorgou E, Kampa M, et al. Potent
inhibitory action of red wine polyphenols on human breast
cancer cells. J Cell Biochem 2000;78:42941.
44. Gehm BD, McAndrews JM, Chien PY, et al. Resveratrol, a
polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A
1997;94:1413843.
45. Longnecker MP. Invited commentary: the Framingham results
on alcohol and breast cancer. Am J Epidemiol 1999;149:
1023.
46. Chu SY, Lee NC, Wingo PA, et al. Alcohol consumption and
the risk of breast cancer. Am J Epidemiol 1989;130:86777.
47. Ewertz M. Alcohol consumption and breast cancer risk in
Denmark. Cancer Causes Control 1991;2:24752.
48. Friedenreich CM, Howe GR, Miller AB. A cohort study of
alcohol consumption and risk of breast cancer. Am J
Epidemiol 1993;137:51220.
49. Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. N Engl J Med 1995;332:
124550.
50. Garfinkel L, Boffetta P, Stellman SD. Alcohol and breast
cancer: a cohort study. Prev Med 1988;17:68693.
51. Harris RE, Namboodiri KK, Wynder EL. Breast cancer risk:
effects of estrogen replacement therapy and body mass. J
Natl Cancer Inst 1992;84:157582.
52. Hiatt RA, Bawol RD. Alcoholic beverage consumption and
breast cancer incidence. Am J Epidemiol 1984;120:67683.
53. Hiatt RA, Klatsky AL, Armstrong MA. Alcohol consumption
and the risk of breast cancer in a prepaid health plan. Cancer
Res 1988;48:22847.
54. Holmberg L, Baron JA, Byers T, et al. Alcohol intake and
breast cancer risk: effect of exposure from 15 years of age.
Cancer Epidemiol Biomarkers Prev 1995;4:8437.
55. Hoyer AP, Engholm G. Serum lipids and breast cancer risk:
a cohort study of 5,207 Danish women. Cancer Causes
Control 1992;3:4038.
56. Levi F, Pasche C, Lucchini F, et al. Alcohol and breast cancer
in the Swiss canton of Vaud. Eur J Cancer 1996;32A:210813.
57. Martin-Moreno JM, Boyle P, Gorgojo L, et al. Alcoholic beverage consumption and risk of breast cancer in Spain. Cancer
Causes Control 1993;4:34553.
58. Meara J, McPherson K, Roberts M, et al. Alcohol, cigarette
smoking and breast cancer. Br J Cancer 1989;60:703.
Am J Epidemiol Vol. 154, No. 8, 2001
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.